97
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Cardiovascular safety of MnDPDP and MnCl2

, , , , &
Pages 740-749 | Accepted 21 Apr 1997, Published online: 04 Jan 2010

References

  • Agata N., Tanaka H., Shigenobu K. Effect of Mn2+ on neonatal and adult rat heart. Initial depression and late augmentation of contractile force. Eur. J. Pharmacol. 1992; 222: 223
  • Archibald F. S., Fridowich I. The scavenging of superoxide radical by manganous complexes. In vitro. Arch. Biochem. Biophys. 1982; 214: 452
  • Asplund A., Grant D., Karlsson J. O. G. Mangafodipir (MnDPDP) and MnCl2-induced endothelium-dependent relaxation in bovine mesenteric arteries. J. Pharmacol. Exp. Ther. 1994; 271: 609
  • Bernardino M. E., Young S. W., Lee J. K. T., et al. Hepatic MR imaging with MnDPDP. Safety, image quality and sensitivity. Radiology 1992; 183: 53
  • Bolton T. B. Mechanisms of action of neurotransmitters and other substances on smooth muscle. Physiol. Rev. 1979; 59: 606
  • Brurok H., Schjøtt J., Berg K., Karlsson J. O. G., Jynge P. Effects of MnDPDP, DPDP and MnCl2 upon cardiac function. An experimental study in the Langendorff perfused rat heart. Invest. Radiol. 1995; 30: 159
  • Brurok H., Schjøtt J., Berg K., Karlsson J. O. G., Jynge P. Effects of MnDPDP, DPDP and MnCl2 on cardiac energy metabolism and Mn-accumulation. An experimental study in the isolated perfused rat heart. Accepted for publication in Invest. Radiol. 1997
  • Brutsaert D. L. Endocardial and coronary endothelial control of cardiac performance. NIPS 1993; 8: 82
  • Chapman R. A., Ellis D. Uptake and loss of manganese from perfused frog ventricles. J. Physiol. (London) 1977; 272: 355
  • Conrad L. L., Trendley R. L., Baxter D. J. Positive in-otropic effect of manganese in dog myocardium. Am. J. Physiol. 1966; 210: 357
  • Coraboeuf E., Vassort G. Effects of some inhibitors of ionic permeabilities on ventricular action potential and contraction of rat and guinea pig hearts. J. Electrocardiol. 1968; 1: 19
  • Davidsson L., Lønnerdal B., Sandström B., Kunz C., Keen C. L. Identification of transferrin as the major plasma carrier protein for manganese introduced orally or intravenously or after in vitro addition in the rat. J. Nutr. 1989; 119: 1461
  • Delahayes J. F. Depolarization induced movement of Mn2+ across the cell membrane in the guinea pig myocardium. Its effect on the mechanical response. Circ. Res. 1975; 36: 713
  • Elizondo G., Fretz C. J., Stark D. D., et al. Preclinical evaluation of MnDPDP. New paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991; 178: 73
  • Fawwas R., Bohdiewicz P., Lavallee D., et al. Use of metal-loporphyrins in diagnostic imaging. Nucl. Med. Biol. 1990; 17: 65
  • Furchgott R. F., Jothianandan D., Gidari A. S. The mechanism of action of LY 83583, a selective inhibitor of endothelium-dependent relaxation. Proc. 31st Congr. Physiol. Sci., Helsinki, 1981; 119
  • Grant D., Holtz E., Zech K. Biodistribution and excretion of 54Mn and 14C labelled MnDPDP in rats and dogs. Rome 1993; 251, Abstract ESMRMB 10th Ann. Congr.
  • Hunter D. R., Haworth R. A., Berkoff H. A. Cellular manganese uptake by the isolated perfused rat heart. A probe for the sarcolemmal calcium channel. J. Mol. Cell. Cardiol. 1981; 13: 823
  • Hustvedt S. O., Grant D., Southon T. E., Zech K. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration. Acta Radiol. 1997; 38: 690
  • Jynge P., Brurok H., Asplund A., . Cardiovascular safety of MnDPDP. Experience from ex vivo and in vivo animal experiments. New developments in contrast agent research, P. A. Rinck, R. N. Muller, et al, 1995; 83, 4th Special Topic Semin. Eur. Magn. Reson. Forum, Mons
  • Karlsson J. O. G., Mortensen E., Pedersen H. K., Sager G., Refsum H. Cardiovascular effects of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure. Acta Radiol. 1997; 38: 750
  • Kasten T. P., Settle S. L., Misko T. P., Currie M. G., Nickols G. A. Manganese potentiation of nitric oxide mediated vascular relaxation. Eur. J. Pharmacol. 1994; 253: 35
  • Keen C. L., Baly D. L., Lønnerdal B. Metabolic effects of high doses of manganese in rats. Biol. Trace Elem. Res. 1984; 6: 309
  • Kliegfield P., Charash B., Placek E., Sos T. A. An-tiarrhythmic effects of manganese chloride in infarcted dogs with observations of the dose-related response of heart rate and ventricular pressure. J. Pharmacol. Ther. 1981; 218: 289
  • Korc M. Manganese homeostasis in humans and its role in disease states. Essential and toxic trace elements in human health and disease, A. S. Prasad. John Wiley & Sons, Chichester 1988; 253
  • Langer G. A., Serena S. D., Nudd L. M. Localization of contractile-dependent Ca. Comparison of Mn and vera-pamil in cardiac and skeletal muscle. Am. J. Physiol. 1975; 229: 1003
  • Lauterbur P. C., Mendonca D. M. H., Rudin A. M. Argumentation of water proton spin-lattice relaxation rates by the in vivo addition of paramagnetic ions. Frontiers of biological energetics, P. C. Duton. Academic Press, New York 1978; 752
  • Lim K. O., Stark D. D., Leese P. T., Pfefferbaum A., Rocklage S. M., Quay S. C. Hepatobiliary MR imaging. First human experience with MnDPDP. Radiology 1991; 178: 79
  • Matsanuga K., Furchgott R. F. Responses of rabbit aorta to nitric oxide and superoxide generated by ultraviolet irradiation of solutions containing inorganic nitrite. J. Pharmacol. Exp. Ther. 1991; 259: 1140
  • Moncada S., Palmer R. M., Higgs E. A. Nitric oxide. Physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991; 43: 109
  • Muhler A. Assessment of myocardial perfusion using contrast-enhanced MR imaging. Current status and future developments. MAGMA 1995; 3: 21
  • Murad F. Drugs used for the treatment of angina. Goodman and Gilman's The pharmacological basis of therapeutics, A. G. Gilman, et al. Pergamon Press, New York 1990; 764
  • Nandedkar A. N., Nurse C. E., Friedberg F. Mn++ binding by plasma proteins. Int. J. Peptide Protein Res. 1973; 5: 279
  • Nelson R. C., Chezmar J. L., Newberry L. B., Malko J. A., Gedgaudas-McClees R. K., Bernardino M. E. Manganese dipyridoxyl diphosphate. Effect of dose, time and pulse sequence on hepatic enhancement in rats. Invest. Radiol. 1991; 26: 569
  • øksendal A. N., Jynge P. Myocardial protection by mic-romolar manganese in the calcium paradox and additive effects of verapamil. Basic Res. Cardiol. 1986; 81: 581
  • Payet M. D., Schamme O. F., Ruiz-Cerette E., Deniers J. M. Inhibitory action of blockers of the slow inward current in the rat myocardium, a study in the steady state and of rate of action. J. Mol. Cell. Cardiol. 1980; 12: 187
  • Pomeroy O. H., Wendland M. F., Wagner S., et al. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, MnDPDP. Invest. Radiol. 1989; 24: 531
  • Rocklage S. M., Van Wagoner M. Hepatobiliary contrast agents. An overview of the development of manganese dipyridoxyl diphosphate (MnDPDP). Liver imaging, current trends, and new techniques, J. T. Ferrucci, D. D. Stark. Andover Medical Publishers Inc., Boston 1990; 374
  • Saeed M., Wendland M. F., Takehara Y., Higgins C. B. Reversible and irreversible injury in the reperfused myocardium. Differentiation with contrast material-enhanced MR imaging. Radiology 1990; 175: 633
  • Schaefer S., Lange R. A., Gutekunst D. P., Parkey R. W., Willerson J. T., Peshock R. M. Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. Invest. Radiol. 1991; 26: 551
  • Sellevold O. F. M., Jynge P., Aarstad K. High performance liquid chromatography. A rapid isocratic method for the determination of creatine compounds and adenine nucleotides in myocardial tissue. J. Mol. Cell. Cardiol. 1986; 18: 517
  • Shaw D. D. Summary of the clinical experience with S095 injection (manganese dipyridoxyl diphosphate, MnDPDP). New developments in contrast agent research, P. A. Rinck, R. N. Muller, 1992; 15, Proc. 3rd Special Topic Semin. Eur. Magn. Reson. Forum, EMRF, Mons
  • Sperelakis N. Physiological principles of cardiac toxicology. Principles of cardiac toxicology, S. I. Baskin. CRC Press, Boca Raton 1991; 71
  • Takeya K., Reiter M. Effect of divalent manganese ions on action potential and contractility of cardiac muscle. Naunyn Schmiedebergs Arch. Pharmacol. 1972; 275: 213
  • Toft K. G., Hustvedt S. O., Grant D., et al. Metabolism and pharmacokinetics of MnDPDP in man. Acta Radiol. 1997; 38: 677
  • Torres C. G., Lundby B., Sterud A. Tufte, McGill S., Gordon P. B., Bjerknes H. Strand. MnDPDP for MR imaging of the liver. Results from the European phase III studies. Acta Radiol. 1997; 38: 631
  • Towart R., Refsum H., Stroissnig H., Karlsson J. O. G. Cardiovascular effects of intravenously administered MnDPDP and MnCl2 in the conscious beagle dog. Can. J. Physiol. Pharmacol. 1994; 72(Suppl. 1)186
  • Wang C., Gordon P. B., Hustvedt S. O., et al. MR imaging properties and pharmacokinetics of MnDPDP in healthy volunteers. Acta Radiol. 1997; 38: 665
  • Wolf G. L., Baum L. Cardiovascular toxicity and tissue proton T1 response to manganese injection in the dog and rabbit. AJR 1983; 141: 193

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.